Cargando…
A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2
At the end of December 2020, the anti-SARS-CoV2 vaccination campaign began in Italy. As the number of vaccinated subjects in the general population has increased, several adverse reactions have been observed and reported. Severe cutaneous adverse reactions (SCARs) induced by drugs or vaccines are ra...
Autores principales: | Schroeder, Jan Walter, Gamba, Chiara, Toniato, Andrea, Rongioletti, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085440/ https://www.ncbi.nlm.nih.gov/pubmed/35550918 http://dx.doi.org/10.1016/j.clindermatol.2022.02.018 |
Ejemplares similares
-
Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021) -
Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa
por: Iannone, Michela, et al.
Publicado: (2021) -
A case of hemichorea following administration of the Pfizer-BioNTech COVID-19 vaccine
por: Ryu, Dong-Woo, et al.
Publicado: (2021) -
Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
por: Hagin, David, et al.
Publicado: (2021) -
The clinical and pathologic spectrum of mucocutaneous reactions after COVID-19 vaccinations in three tertiary referral centers of northern Italy
por: Paolino, Giovanni, et al.
Publicado: (2023)